Background and Aims Intestinal alkaline phosphatase (IAP) is a gut mucosal defense factor known to dephosphorylate lipopolysaccharide (LPS); however, the role of IAP in the gut response to luminal bacteria remains poorly defined. We investigated immune responses of wild-type (WT) and IAP-knockout (IAP-KO) mice to LPS and Salmonella typhimurium challenges. Methods Cryostat sectioning and standard indirect immunohistochemical staining for major histocompatibility complex (MHC) class II molecules were performed on liver tissue from WT and IAP-KO mice. WT and IAP-KO mice were orally gavaged with S. typhimurium; bacterial translocation to mesenteric nodes, liver, and spleen was determined by tissue homogenization and plating. In other experiments, WT and IAP-KO mice received intraperitoneal injections of LPS, with subsequent quantification of complete blood counts and serum interleukin (IL)-6 by enzyme-linked immunosorbent assay (ELISA). WT and IAP-KO whole blood were plated and stimulated with LPS and Pam-3-Cys, followed by cytokine assays. Results Immunohistologic liver examinations showed increased expression of MHC class II molecules in IAP-KO mice. Following S. typhimurium challenge, WT mice appeared moribund compared with IAP-KO mice, with increased bacterial translocation. WT mice had [50% decrease (P \ .005) in platelets and 1.8-fold (P \ .05) increased serum IL-6 compared with IAP-KO mice in response to LPS injections. IAP-KO whole-blood stimulation with LPS and Pam-3-Cys resulted in increased IL-6 and tumor necrosis factor (TNF)-alpha secretion compared with WT. Sci (2011) 56:1020-1027 DOI 10.1007/s10620-010-1396 Conclusions IAP-KO mice exhibit characteristics consistent with local LPS tolerance. Whole-blood response of IAP-KO mice did not reflect systemic tolerance. These data suggest that IAP is a local immunomodulating factor, perhaps regulating LPS-toll-like receptor 4 (TLR4) interaction between commensal microflora and intestinal epithelium.
Introduction
The precise physiological role for the small intestinal brush border enzyme intestinal alkaline phosphatase (IAP) remains incompletely understood. To date, IAP is best understood as a gut mucosal defense factor. We and others have shown that IAP has the ability to detoxify Gram-negative bacterial endotoxin lipopolysaccharides (LPS) through a dephosphorylation process [1] [2] [3] [4] . IAP expression is silenced during times of fasting, which is concordant with a decrease in LPS dephosphorylating activity [5] , and is associated with increased bacterial translocation and gut-derived sepsis [6, 7] . In fact, we have demonstrated that IAP-knockout (IAP-KO) mice experience increased bacterial translocation when subjected to direct or indirect gut injury [1] .
Although IAP appears to function in gut mucosal defense, under normal conditions IAP-KO mice survive without apparent difficulty or increased infection rates. In fact, the only phenotype initially described for IAP-KO mice was obesity when fed a high-fat diet, an effect thought to be due to accelerated fat absorption [8, 9] . However, there is some evidence that IAP plays a role in gut immune function; for example, inflammatory bowel disease appears to result from a dysregulated mucosal immune response to bacterial components such as LPS. Furthermore, presence of luminal bacteria is necessary for development of spontaneous murine colitis [10, 11] . Low IAP activity has been documented in patients with active inflammatory bowel disease [12, 13] ; in fact, IAP levels in even noninflamed tissues in IBD patients are decreased as well [13] . It is conceivable that IAP may play a role in dephosphorylating LPS from commensal microflora and decoupling its interaction with TLR4 receptors in epithelial cells or resident gut macrophages, thus keeping the immune system in check. Although IAP-KO mice do not exhibit spontaneous colitis, we have shown that they are more susceptible to experimental colitis (unpublished observations), and Tuin et al. showed a protective effect of oral IAP supplementation in the setting of dextran sodium sulfate (DSS)-induced murine colitis [13] .
Given these data on IAP function, we sought to further explore its role in regard to gut immunity. We speculated that WT mice would be able to normally dephosphorylate and detoxify intraluminal intestinal LPS, thus limiting gut/ portal exposure to intact LPS. In contrast, since IAP-KO mice have decreased capacity to detoxify LPS, these animals would be continuously exposed to active, intact LPS from endogenous intestinal flora. We hypothesized that the excessive chronic exposure to intact LPS in these IAP-KO mice would result in development of tolerance to endotoxin.
The concept of LPS tolerance is complex; on the one hand, some degree of tolerance is desirable as a way to limit the host inflammatory response, whereas extreme suppression of the host immune response would be detrimental. Mice with induced endotoxin tolerance have alternately been shown to be more resistant to certain infections, such as S. typhimurium and Cryptococcus infections [14, 15] , yet more susceptible to others, such as E. coli [16] . With these observations in mind, characterization of the immune responses of IAP-KO mice compared with their WT littermates was undertaken to delineate the role of endogenous IAP in the gut responses to bacteria and LPS. We show here that lack of IAP has a demonstrable impact on LPS responsiveness, and that IAP-KO mice appear to develop tolerance to LPS compared with their WT counterparts.
Materials and Methods

Chemicals
Mouse IL-6 and TNF-alpha OptEIA ELISA kits and reagents (BD Biosciences, San Diego, CA) were used for serum cytokine analyses. Ultra pure E. coli LPS (Invivogen, San Diego, CA) was obtained as a lyophilized pellet and reconstituted in sterile water as directed for mouse intraperitoneal injection studies. For whole-blood stimulation studies, E. coli LPS (List Biologicals, Campbell, CA) and Pam-3-Cys (EMC Microcollections GMBH, Tuebingen, Germany) were used. Streptomycin sulfate (Gibco, San Diego, CA) was obtained as a powder and reconstituted in Luria-Bertani broth as needed.
Bacterial Culture
Salmonella typhimurium was obtained as a kind gift from Hans Christian Reinecker's laboratory (MGH, Boston, MA). Bacteria were grown in culture in Luria-Bertani media at 37°C overnight as needed.
Animals
IAP-KO mice (Mus musculus C57BL/6) construction has been previously described [8] . Heterozygous mice were obtained from the Burnham Institute for Medical Research (La Jolla, CA) and subsequently bred at the MGH animal facility to acquire homozygous IAP-KO and WT C57BL/6 littermates. Genotype was confirmed by polymerase chain reaction (PCR) analysis. Animals in this work were maintained in accordance with the guidelines of the Committee on Animals of Harvard Medical School (Boston, MA) and those prepared by the Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Resources and the National Institutes of Health [17] .
Hepatic Immunohistological Examination
WT (n = 6) and IAP-KO (n = 9) mice were sacrificed by carbon dioxide inhalation, and liver cryostat sectioning was performed (thickness 4 lm). Liver sections were fixed in acetone at 4°C. A rat monoclonal antibody against a subunit of mouse MHC class II molecule was used as a primary antibody (sc-59318; Santa Cruz Biotechnology Inc, Santa Cruz, CA); rabbit anti-rat IgG was used as a secondary antibody (Vector Laboratories, Burlingame, CA), followed by hybridization with horseradish peroxidaseconjugated goat anti-rabbit IgG (Vector Laboratories). Diaminobenzidine (DAB; Sigma-Aldrich, St. Louis, MO) was used as the peroxidase substrate for chromogenic visualization of the target protein.
Salmonella Gavage in WT and IAP-KO Mice
WT and IAP-KO mice (n = 5 per group) were fasted for 4 h, and then given an oral gavage of streptomycin (100 mg/kg). Food and water were then returned ad libitum. Twenty-four hours later, food and water were again withheld for 4 h, and each mouse was then orally gavaged with 10 6 colony forming units (CFU) of S. typhimurium; controls from each WT and IAP-KO group were gavaged with an equal volume of Luria-Bertani broth. Food and water were then resumed ad libitum. Daily weights and appearances of these mice were recorded. Six days after gavage of S. typhimurium, all mice were sacrificed. Mesenteric lymph nodes, spleen, and liver were harvested and weighed. Each organ was homogenized in 1 mL phosphate-buffered saline (PBS); samples were serially diluted and plated on Luria-Bertani agar plates overnight at 37°C. Bacterial CFUs were counted the following morning; these values are expressed as mean CFU/g tissue.
In Vivo Response to LPS
WT and IAP-KO mice (male, 9-12 weeks, n = 5) were injected intraperitoneally (IP) with 100 lg LPS. After 2 h, mice were sacrificed. Blood was withdrawn by cardiac puncture and collected in a microcentrifuge tube. Twenty-five microliters of whole blood was submitted to the MGH Center for Comparative Medicine (CCM) for complete blood count analysis. The remainder of the blood was centrifuged at 13,200 rpm (16,300g) for 5 min in a microcentrifuge, and the serum fraction was collected for quantification of IL-6 by ELISA.
Whole-Blood Stimulation with LPS WT and IAP-KO mice (male, n = 8 and 9, respectively) were exsanguinated using heparinized syringes. Blood was diluted 1:4 in Roswell Park Memorial Institute (RPMI) media and plated for 1 h. Blood was then stimulated overnight by addition of LPS (20-2,000 lg) or Pam-3-Cys (20-2,000 lg). Plates were centrifuged, and supernatants were assayed for IL-6 and TNF-alpha by ELISA.
Statistical Analysis
Cytokine response experiments in WT and IAP-KO mice in response to intraperitoneal injection of LPS were performed three times with consistent results. Whole-blood stimulation with LPS and Pam-3-Cys was performed with blood samples from eight WT and nine IAP-KO mice, respectively. S. typhimurium gavage experiments were performed four times, with varying ages and time to sacrifice after gavage (n = 3-5 and 5 for WT and IAP-KO mice, respectively), but the results were consistent from experiment to experiment. The data presented are for a representative experiment. Statistical significance was calculated by performing an unpaired, one-tailed Student's t-test between WT and IAP-KO groups. The significance level was set to P \ .05.
Results
MHC Class II Molecules Are Overexpressed in IAP-KO Mouse Liver
Because enteric antigens, including LPS, are cleared through the liver, we were first interested in examining MHC class II protein expression in WT and IAP-KO mice. Consistent with our speculation that IAP-KO mice are exposed to more active enteric endotoxin, immunohistology performed on the livers showed upregulation of MHC class II molecules in IAP-KO mice compared with WT mice (Fig. 1) . The staining pattern was consistent with localization of Kupffer cells (KC) in the parenchyma. There was no difference in the number of KC present in these livers as reflected by F4/80 staining (results not shown).
IAP-KO Mice Exhibit Resistance to Systemic Dissemination of S. typhimurium
WT and IAP-KO mice were then compared in regard to their sensitivity to an oral bacterial challenge. We chose S. typhimurium because mice are readily susceptible to oral challenge with this bacterium. Furthermore, animal responses to S. typhimurium infection have been well described in the setting of LPS tolerance, with endotoxintolerant mice exhibiting prolonged survival and decreased bacterial loads [14] . When WT and IAP-KO mice were gavaged with S. typhimurium, both groups exhibited weight loss; however, WT mice on average lost significantly more weight and appeared sicker than IAP-KO mice (Fig. 2a) . Furthermore, WT mice had increased bacterial translocation to the mesenteric nodes, spleen, and liver, with three-, eight-, and fourfold increases in CFUs compared with IAP-KO mice (P \ .05; Fig. 2b ).
IAP-KO Mice Are Tolerant to LPS-Mediated Immune Response
The observation that IAP-KO mice were relatively resistant to S. typhimurium provided evidence for the development of endotoxin tolerance in IAP-KO mice. We sought to further define this immune response by exposing the mice to systemic LPS. In our experiments (unpublished), we found that serum IL-6 peaks at 2 h after IP injection of LPS, and cytokine and whole-blood studies were performed accordingly. There was no difference in serum IL-6 levels between WT and IAP-KO mice injected with normal saline. However, following IP injection of LPS, WT mice demonstrated increased immune response compared with IAP-KO mice. Platelet counts were decreased by [50% (P \ .005) in WT mice compared with IAP-KO mice (Fig. 3b) . Serum IL-6 was also increased by 1.8-fold (P \ .05) in WT mice compared with IAP-KO mice (Fig. 3c) . There was no difference in white blood cell (WBC) counts between the two groups, although both (Fig. 3a) .
Whole-Blood Experiments to Assess Systemic Tolerance
Finally, we performed whole-blood experiments to determine whether the LPS tolerance in IAP-KO mice was confined to the gut/portal system or was systemically evident. Whole blood was stimulated by both LPS and Pam-3-Cys, and resulted in [2-fold increases (P \ .005) in IL-6 secretion in IAP-KO samples compared with the WT blood (Fig. 4) . TNF-alpha release was also increased in IAP-KO samples, although this did not reach statistical significance. This result indicates that the LPS tolerance exhibited by IAP-KO mice is confined to the gut/portal system.
Discussion
Intestinal alkaline phosphatase is well known to have the ability to dephosphorylate LPS, and we have previously demonstrated that its expression in the intestine correlates directly with LPS dephosphorylating activity in the gut [1] . When IAP expression is decreased in the setting of starvation, LPS dephosphorylating activity is also diminished. In addition, IAP-KO mice have less LPS dephosphorylating activity compared with their WT littermates [1] . Based upon these observations, we have speculated that IAP has a role in regulating the host response to active endotoxin.
Commensal microflora serves important functions in regard to vitamin synthesis, nutrient digestion, and competitive inhibition of pathogen colonization. However, these bacteria also represent a major antigen burden within the intestinal lumen. IAP, which is both membrane bound and secreted into the lumen, may serve as a mucosal defense factor by dephosphorylating and detoxifying this burden. Breakdown of the gut mucosal barrier can result in increased endotoxemia and LPS-induced hepatitis and Kupffer cell activation [18, 19] . Accordingly, we hypothesized that, by limiting exposure to intact endotoxin, the IAP enzyme could be providing an important protective function to the host.
Under normal conditions in WT mice, the LPS that crosses the intestinal brush border would be expected to be in a dephosphorylated (inactive) form, having been exposed to IAP. In contrast, IAP-KO mice lack the ability to detoxify LPS in this manner, and these mice would therefore be continuously exposed to intact and active LPS. As such, over time, the IAP-KO mice would be expected to become tolerant to LPS. We designed a series of experiments to test this hypothesis. We found that Kupffer cell MHC class II molecules are upregulated in IAP-KO mice. LPS is known to activate MHC class II molecules in liver tissue, especially Kupffer cells [20] [21] [22] [23] [24] . In regard to bacterial infection, endotoxintolerant mice have generally been shown to be resistant to various aspects of sepsis, including vasomotor collapse and fever [25, 26] . In particular, it has been shown that mice in which LPS tolerance has been induced are resistant to Salmonella infection [14, 27] , which is what we observed in the IAP-KO mice. The IAP-KO mice had decreased weight loss, appeared healthier, and, following oral inoculation of S. typhimurium, had decreased bacterial translocation to mesenteric nodes and distant organs compared with WT mice. Lastly, we demonstrated LPS tolerance in IAP-KO mice in the classical sense of the definition, which is described as hyporesponsiveness to endotoxin following previous sublethal exposure to endotoxin [28, 29] . Previous studies have shown that monophosphoryl LPS is unable to induce an equivalent tolerance to that provoked by intact LPS [30, 31] , and that increased concentrations of monophosphoryl LPS are needed to match the initial cytokine response induced by that of intact LPS. In accordance with this idea of tolerance, we observed that IAP-KO mice had blunted immune response to intraperitoneal injections of LPS; the platelet drop was not as dramatic as in WT mice, nor was the increase in serum IL-6 as high. Taken together, these data suggest that the IAP-KO mice are indeed exposed to active endotoxin across the gut barrier and, as a consequence, have developed a tolerance to LPS and bacterial pathogens.
In contrast to the gut/portal system LPS tolerance noted in the IAP-KO mice, we found that whole-blood responsiveness of the IAP-KO mice was not less than that seen in WT mice. It appears, therefore, that the tolerance we observe in IAP-KO mice is confined to the local gut/ portal system environment. Following LPS injection into the bloodstream, the majority of the LPS is cleared in the liver [32, 33] ; this, along with other LPS binding factors in whole blood, inhibits the contact between LPS and circulating leukocytes [34] [35] [36] [37] . Serum IL-6 production after LPS injection is largely driven by the portal system; LPS levels following intraperitoneal LPS injection are higher in the portal system than in the arterial system, with subsequent hepatically derived TNF-alpha release [38, 39] . Furthermore, serum IL-6 following LPS injection is driven by TNF-alpha production as well [40] . Thus, gut tolerance to LPS may not translate to systemic tolerance to LPS, as demonstrated by whole-blood responsiveness in the present studies. Interestingly, Fitting et al. demonstrated that endotoxin tolerance can be compartmentalized [41] . Following IP LPS injections in mice, they observed that alveolar leukocytes did not demonstrate the same level of tolerance as peritoneal and bone marrow cells or splenocytes. Furthermore, they found using whole-blood studies that in vivo tolerance did not translate into prolonged ex vivo tolerance. Our findings with IAP-KO mice are consistent with these observed differences between in vivo and ex vivo LPS tolerance. Lastly, we note that, with our whole-blood studies, not only was LPS tolerance not demonstrated, but IAP-KO whole blood in fact exhibited increased cytokine production over that of WT whole blood when stimulated with LPS and Pam-3-Cys. The reason for this is not clear. Possibilities could include increased sensitivity of circulating leukocytes, decreased suppressive plasma proteins, increased facilitating plasma proteins, or some combination. Further studies will be required to elucidate the underlying mechanisms.
Based on our present data, we believe that IAP functions as a local immunomodulating factor in the intestine. Several recent papers support the idea that TLR pathways in the intestinal epithelium are integral to maintaining intestinal-commensal microflora homeostasis [42] [43] [44] ; in essence, some degree of TLR signaling by commensal bacteria is necessary to maintain normal intestinal surface structure and the capacity for repair in response to injury. However, a balance is required, as hyperactive TLR signaling can lead to increased intestinal inflammation, such as that seen in inflammatory bowel disease. Although in our present studies we demonstrate an advantage to LPS tolerance in terms of salmonellosis, this observation does not necessarily correlate with an advantage in terms of commensal microflora. S. typhimurium is a particular pathogen that is not dependent on LPS for invasion or recognition by host defenses (in fact, LPS-deficient Salmonella are cleared more rapidly from the bloodstream, which may explain why LPS tolerance is beneficial in this case) [44] . In contrast to S. typhimurium, we have previously demonstrated that IAP-KO mice are more susceptible to bacterial translocation from the gut in response to mesenteric and hind-limb ischemia [1] . With our present data and previous observations, we believe that IAP plays a role in LPS-TLR4 interaction, limiting host tolerance to commensal microflora and thereby helping to maintain the balance and integrity of the gut mucosal barrier.
